A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma
Clinical trial NCT04990271 · UNKNOWN
Trial details
- NCT number
- NCT04990271
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2023-04-15
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.